Watching this one for a bounce. Best to all.

$5

REPH will have a major run one day....

not because of any chart but for the painkiller product!

* * $REPH Video Chart 12-14-2020 * *

Link to Video - click here to watch the technical chart video

i'M IN

Very Nice! $REPH

$4.10 :) nice

All the CEO has done is unload her shares all year long

Got 200 jan 5$ calls for .05 really cheap up 600% now gonna make a big move on Monday. Stay tuned

REPH has room to run here

Bottom looks to be in

Breakout watch here ~

$RPEH down 40% as if it were about to declare BK.

Yet, 2020 guidance says:

"The Company expects its Operating Income to be in the range of $5 million to $9 million and Operating income, as adjusted* to be in the range of $13 million to $17 million. EBITDA, as adjusted (Historical CDMO) to be in the range of $33 million to $37 million and EBITDA, as adjusted (Standalone)* to be in the range of $26 million to $30 million."


Took a starter today. Might take a bit to recover but I can be patient.

$REPH daily chart: That was a WOW Move...

* * $REPH Video Chart 04-04-2019 * *

Link to Video - click here to watch the technical chart video

* * $REPH Video Chart 05-24-18 * *

Link to Video - click here to watch the technical chart video

$4 will be next support

REPH Does NOT meet primary endpoint of FDA= Unable to approve
https://ih.advfn.com/p.php?pid=nmona&article=77510597

LYTTON LAURENCE W has filed a new 13G, reporting 6.2% ownership in $REPH - https://fintel.io/so/us/reph

http://marketexclusive.com/recro-pharma-inc-nasdaqreph-heres-whats-next/41372/

http://www.smarteranalyst.com/2016/11/28/stock-update-nasdaqreph-heres-recro-pharma-inc-shares-jumped-22-today/

P3 data was widely expected to be positive IMO.

It's time for REPH to shine again!

Phase III results for Meloxicam are due to be reported in both the third and fourth quarter of this year.

If positive - and there is NO reason to think they will not be - this stock will see new highs relatively quickly.

Meloxicam if approved next year, should give the company a 500 million dollar market cap. Right now it stands at a mere $75 million so upside for the next 12 months is over 500%. Not sure if the 500 million market cap would be realized immediately upon approval or not - probably would take a bit longer, but once meloxicam begins to grab a market share, the market cap will rise significantly.

Maybe 500% within a year is too high, but certainly will be 3-4X with FDA approval which could come in a year.

Now is the time to get in!

I am long REPH, although my position is small. Wish I had a lot of free funds to invest. Oh well. Start where you are at and build.

$REPH recent news/filings

bullish 8.97
thinking it will bounce from oversold from here for a while
hammer candlesticks
61.8% fib retracement like before

## source: finance.yahoo.com

Thu, 19 Nov 2015 18:04:27 GMT ~ RECRO PHARMA, INC. Financials


read full: http://finance.yahoo.com/q/is?s=reph
*********************************************************

Tue, 17 Nov 2015 21:38:07 GMT ~ RECRO PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition


read full: http://biz.yahoo.com/e/151117/reph8-k.html
*********************************************************

Fri, 13 Nov 2015 15:46:09 GMT ~ Recro Pharma Reports Third Quarter 2015 Financial Results

[at noodls] - 9b2ff286-4706-4f26-ad58-f6383d1052f8.pdf MALVERN, PA, November 13, 2015 - Recro Pharma, Inc. (Nasdaq: REPH), a revenue generating specialty pharmaceutical company developing multiple non-opioid therapeutics ...

read full: http://www.noodls.com/view/6EA697AA3AA9709D49BFAA8272FE6E4944116292
*********************************************************

Fri, 13 Nov 2015 12:30:14 GMT ~ RECRO PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi


read full: http://biz.yahoo.com/e/151113/reph8-k.html
*********************************************************

Fri, 13 Nov 2015 12:00:00 GMT ~ Recro Pharma Reports Third Quarter 2015 Financial Results

[GlobeNewswire] - MALVERN, Pa. -- Recro Pharma, Inc. , a revenue generating specialty pharmaceutical company developing multiple non-opioid therapeutics for the treatment of pain, today reported financial results for the ...

read full: http://finance.yahoo.com/news/recro-pharma-reports-third-quarter-120000872.html
*********************************************************

$REPH charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$REPH company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/REPH/company-info
Ticker: $REPH
OTC Market Place: Not Available
CIK code: not found
Company name: Recro Pharma, Inc.
Incorporated In:


$REPH share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available

$REPH extra dd links

Company name: Recro Pharma, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/REPH/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/REPH/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=REPH+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=REPH+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=REPH+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/REPH/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/news - http://finance.yahoo.com/q/h?s=REPH+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/REPH/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/REPH/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/REPH/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/REPH/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/REPH/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/REPH/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/REPH/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=REPH+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/REPH
DTCC (dtcc.com): http://search2.dtcc.com/?q=Recro+Pharma%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Recro+Pharma%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Recro+Pharma%2C+Inc.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/REPH/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/REPH
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/REPH/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/REPH/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/REPH/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/REPH/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/REPH/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=REPH&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=REPH
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=REPH+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=REPH+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=REPH
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=REPH
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=REPH+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/REPH/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=REPH+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/REPH.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=REPH
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/REPH/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/REPH/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/REPH/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/REPH
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/REPH
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/REPH:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=REPH
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=REPH



$REPH DD Notes ~ http://www.ddnotesmaker.com/REPH

$REPH recent news/filings

turned bearish 9.47

## source: finance.yahoo.com

Fri, 13 Nov 2015 15:46:09 GMT ~ Recro Pharma Reports Third Quarter 2015 Financial Results

[at noodls] - 9b2ff286-4706-4f26-ad58-f6383d1052f8.pdf MALVERN, PA, November 13, 2015 - Recro Pharma, Inc. (Nasdaq: REPH), a revenue generating specialty pharmaceutical company developing multiple non-opioid therapeutics ...

read full: http://www.noodls.com/view/6EA697AA3AA9709D49BFAA8272FE6E4944116292
*********************************************************

Fri, 13 Nov 2015 12:30:14 GMT ~ RECRO PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi


read full: http://biz.yahoo.com/e/151113/reph8-k.html
*********************************************************

Fri, 13 Nov 2015 12:00:00 GMT ~ Recro Pharma Reports Third Quarter 2015 Financial Results

[GlobeNewswire] - MALVERN, Pa. -- Recro Pharma, Inc. , a revenue generating specialty pharmaceutical company developing multiple non-opioid therapeutics for the treatment of pain, today reported financial results for the ...

read full: http://finance.yahoo.com/news/recro-pharma-reports-third-quarter-120000872.html
*********************************************************

Thu, 12 Nov 2015 16:56:05 GMT ~ Recro Pharma to Participate in Upcoming Investor Conferences

[at noodls] - adcbbc10-c73a-4e6e-a890-ed47f5dd8d20.pdf MALVERN, PA, November 12, 2015 - Recro Pharma, Inc. (Nasdaq: REPH), a revenue generating specialty pharmaceutical company developing multiple non-opioid therapeutics ...

read full: http://www.noodls.com/view/D2992B3B4D7B7775E1B0C57713AD3680F00CAEAA
*********************************************************

Thu, 12 Nov 2015 12:00:00 GMT ~ Recro Pharma to Participate in Upcoming Investor Conferences

[GlobeNewswire] - MALVERN, Pa. -- Recro Pharma, Inc. , a revenue generating specialty pharmaceutical company developing multiple non-opioid therapeutics for the treatment of pain, today announced that Gerri Henwood, the ...

read full: http://finance.yahoo.com/news/recro-pharma-participate-upcoming-investor-120000875.html
*********************************************************

$REPH charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$REPH company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/REPH/company-info
Ticker: $REPH
OTC Market Place: Not Available
CIK code: not found
Company name: Recro Pharma, Inc.
Incorporated In:


$REPH share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available

$REPH extra dd links

Company name: Recro Pharma, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/REPH/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/REPH/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=REPH+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=REPH+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=REPH+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/REPH/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/news - http://finance.yahoo.com/q/h?s=REPH+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/REPH/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/REPH/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/REPH/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/REPH/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/REPH/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/REPH/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/REPH/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=REPH+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/REPH
DTCC (dtcc.com): http://search2.dtcc.com/?q=Recro+Pharma%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Recro+Pharma%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Recro+Pharma%2C+Inc.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/REPH/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/REPH
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/REPH/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/REPH/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/REPH/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/REPH/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/REPH/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=REPH&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=REPH
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=REPH+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=REPH+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=REPH
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=REPH
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=REPH+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/REPH/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=REPH+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/REPH.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=REPH
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/REPH/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/REPH/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/REPH/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/REPH
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/REPH
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/REPH:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=REPH
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=REPH



$REPH DD Notes ~ http://www.ddnotesmaker.com/REPH

$REPH recent news/filings

bullish
bull flag breakout
starting next rally up
stochastics crossing up
hammer candlestick
acc/dist and obv above average and climbing
long term inverted head and shoulders pattern

## source: finance.yahoo.com

Wed, 02 Sep 2015 21:48:09 GMT ~ These 7 Stocks Have Crushed the Market in 2015


read full: http://finance.yahoo.com/news/7-stocks-crushed-market-2015-214809328.html
*********************************************************

Wed, 02 Sep 2015 14:58:47 GMT ~ Non-Opioid Therapeutics And Significant Pain Treatments Make For A Buy Rating


read full: http://finance.yahoo.com/news/non-opioid-therapeutics-significant-pain-145847475.html
*********************************************************

Wed, 02 Sep 2015 11:27:45 GMT ~ Coverage initiated on Recro Pharma by H.C. Wainwright


read full: http://finance.yahoo.com/q/ud?s=REPH
*********************************************************

Fri, 28 Aug 2015 17:04:10 GMT ~ RECRO PHARMA, INC. Financials


read full: http://finance.yahoo.com/q/is?s=reph
*********************************************************

Fri, 28 Aug 2015 15:59:56 GMT ~ Recro Pharma, Inc. Earnings Q2, 2015


read full: http://www.capitalcube.com/blog/index.php/recro-pharma-inc-earnings-q2-2015/
*********************************************************

$REPH charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$REPH company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/REPH/company-info
Ticker: $REPH
OTC Market Place: Not Available
CIK code: not found
Company name: Recro Pharma, Inc.
Incorporated In:

$REPH share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available

$REPH extra dd links

Company name: Recro Pharma, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/REPH/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/REPH/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=REPH+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=REPH+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=REPH+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/REPH/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/news - http://finance.yahoo.com/q/h?s=REPH+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/REPH/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/REPH/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/REPH/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/REPH/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/REPH/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/REPH/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/REPH/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=REPH+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/REPH
DTCC (dtcc.com): http://search2.dtcc.com/?q=Recro+Pharma%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Recro+Pharma%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Recro+Pharma%2C+Inc.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/REPH/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/REPH
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/REPH/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/REPH/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/REPH/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/REPH/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/REPH/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=REPH&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=REPH
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=REPH+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=REPH+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=REPH
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=REPH
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=REPH+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/REPH/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=REPH+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/REPH.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=REPH
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/REPH/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/REPH/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/REPH/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/REPH
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/REPH
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/REPH:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=REPH
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=REPH



$REPH DD Notes ~ http://www.ddnotesmaker.com/REPH

Anemic volume, no more pump posts. Ahh ain't that a shame? Last one out hit the lights James Hetfield style! ;)

Looking for a retrace

HUGE ANALYST RATING > Thomson Reuters gives REPH a positive 8-scale rating initiated July 15, 2015.

7 Million float > moves easily!

Moving up nicely in PM!

REPH is a great $$$$$ opportunity.

Some folks, and shorts that are negative on REPH are crying in their beer today.

HUGE UPSIDE TODAY!!!!!

And why do you think that? Just based on how it's trading?

Next leg to $ 25

damn screwed myself. I sold at 9.77 and it dropped to 8.99 and I didn't get back in. Now it's 11.15. I have 1/3 my holdings left, bummer I missed out on a lot more.

$REPH recent news/filings

turned bullish

## source: finance.yahoo.com

Tue, 02 Jun 2015 18:53:09 GMT ~ RECRO PHARMA, INC. Files SEC form 8-K/A, Financial Statements and Exhibits


read full: http://biz.yahoo.com/e/150602/reph8-k_a.html
*********************************************************

Thu, 28 May 2015 18:48:08 GMT ~ RECRO PHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits


read full: http://biz.yahoo.com/e/150528/reph8-k.html
*********************************************************

Thu, 28 May 2015 13:46:11 GMT ~ Recro Pharma to Present at the Jefferies 2015 Global Healthcare Conference

[at noodls] - Recro Pharma to Present at the Jefferies 2015 Global Healthcare Conference MALVERN, PA, May 28, 2015 - Recro Pharma, Inc. (Nasdaq: REPH), a revenue generating specialty pharmaceutical company developing ...

read full: http://www.noodls.com/view/1D8CE6DA1AD9388448C7531A02DC8527B8E7F68F
*********************************************************

Thu, 28 May 2015 11:00:00 GMT ~ Recro Pharma to Present at the Jefferies 2015 Global Healthcare Conference

[GlobeNewswire] - MALVERN, Pa. -- Recro Pharma, Inc. , a revenue generating specialty pharmaceutical company developing multiple non-opioid therapeutics for the treatment of acute post operative pain, today announced that ...

read full: http://finance.yahoo.com/news/recro-pharma-present-jefferies-2015-110000338.html
*********************************************************

Fri, 22 May 2015 17:04:23 GMT ~ RECRO PHARMA, INC. Financials


read full: http://finance.yahoo.com/q/is?s=reph
*********************************************************

$REPH charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$REPH company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/REPH/company-info
Ticker: $REPH
OTC Market Place: Not Available
CIK code: not found
Company name: Recro Pharma, Inc.
Incorporated In:


$REPH share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available

$REPH extra dd links

Company name: Recro Pharma, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/REPH/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/REPH/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=REPH+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=REPH+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=REPH+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/REPH/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/news - http://finance.yahoo.com/q/h?s=REPH+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/REPH/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/REPH/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/REPH/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/REPH/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/REPH/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/REPH/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/REPH/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=REPH+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/REPH
DTCC (dtcc.com): http://search2.dtcc.com/?q=Recro+Pharma%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Recro+Pharma%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Recro+Pharma%2C+Inc.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/REPH/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/REPH
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/REPH/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/REPH/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/REPH/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/REPH/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/REPH/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=REPH&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=REPH
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=REPH+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=REPH+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=REPH
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=REPH
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=REPH+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/REPH/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=REPH+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/REPH.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=REPH
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/REPH/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/REPH/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/REPH/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/REPH
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/REPH
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/REPH:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=REPH
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=REPH



$REPH DD Notes ~ http://www.ddnotesmaker.com/REPH

Help me understand....

I'm newer to buying stock and first bought in at $13.60, it immediately went down 35% the next day and has bounced around for a month.

I've been doubling down, buying more every time it bottoms out, I bought in at 13.60, 10.50, 8.80, and 7.50 bringing my cost average to 9.20/share.

Now it's going nuts? I put an order in to sell 20% of my holding last night for $9.27 since it'd gone up 10% in a single day, and it just sold at 9.77!

Every other time it goes up 10% in a day, it corrects the following day. What's different today?

I'm reading through their latest PR/income and it looks like they're losing more money than ever? But obviously it's the nature of this type of business, but I'm trying to understand why it's rocketing at the moment? Good news somewhere? People speculating on the trials going on? WTH is going on?

$REPH recent news/filings

bearish
head and shoulders

## source: finance.yahoo.com

Tue, 12 May 2015 23:16:25 GMT ~ Recro Pharma Reports First Quarter 2015 Financial Results

[at noodls] - ? Strengthened Company with Acquisition of Phase III-Ready IV/IM Meloxicam, Cash Flow Positive Manufacturing/Formulation Business from Alkermes ? ? Encouraging Dex-IN Interim Analysis Results Support Continuation ...

read full: http://www.noodls.com/view/C7A37B5FA04732E00DDD2E8EB843EE1DEED16932
*********************************************************

Tue, 12 May 2015 22:03:15 GMT ~ Recro Pharma Reports First Quarter 2015 Financial Results

[GlobeNewswire] - Strengthened Company with Acquisition of Phase III-Ready IV/IM Meloxicam, Cash Flow Positive Manufacturing/Formulation Business from Alkermes

read full: http://finance.yahoo.com/news/recro-pharma-reports-first-quarter-220315476.html
*********************************************************

Tue, 12 May 2015 21:27:17 GMT ~ RECRO PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Stateme


read full: http://biz.yahoo.com/e/150512/reph8-k.html
*********************************************************

Wed, 29 Apr 2015 22:15:16 GMT ~ Nasdaq stocks posting largest percentage decreases

[AP] - A look at the 10 biggest percentage decliners on Nasdaq at the close of trading: Ohr Pharmaceutical fell 32.1 percent to $7.74. Web.com Inc. fell 19.9 percent to $27.70. Aemetis Inc. fell 12.5 percent ...

read full: http://sg.finance.yahoo.com/news/nasdaq-stocks-posting-largest-percentage-220242625--finance.html
*********************************************************

Mon, 27 Apr 2015 13:12:01 GMT ~ Will Recro Pharma (REPH) Continue to Surge Higher? - Tale of the Tape


read full: http://finance.yahoo.com/news/recro-pharma-reph-continue-surge-131201831.html
*********************************************************

$REPH charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$REPH company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/REPH/company-info
Ticker: $REPH
OTC Market Place: Not Available
CIK code: not found
Company name: Recro Pharma, Inc.
Incorporated In:

$REPH share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available

$REPH extra dd links

Company name: Recro Pharma, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/REPH/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/REPH/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=REPH+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=REPH+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=REPH+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/REPH/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/news - http://finance.yahoo.com/q/h?s=REPH+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/REPH/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/REPH/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/REPH/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/REPH/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/REPH/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/REPH/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/REPH/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=REPH+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/REPH
DTCC (dtcc.com): http://search2.dtcc.com/?q=Recro+Pharma%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Recro+Pharma%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Recro+Pharma%2C+Inc.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/REPH/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/REPH
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/REPH/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/REPH/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/REPH/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/REPH/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/REPH/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=REPH&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=REPH
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=REPH+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=REPH+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=REPH
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=REPH
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=REPH+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/REPH/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=REPH+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/REPH.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=REPH
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/REPH/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/REPH/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/REPH/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/REPH/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/REPH
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/REPH
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/REPH:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=REPH
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=REPH



$REPH DD Notes ~ http://www.ddnotesmaker.com/REPH

Clinical trials reports next month?

Second leg begins to $ 20

No worries the company is in much better position added 2000 shares at 9.00

REPH churning and burning... Too much negativity surrounding this co. They screwed up P2 study then reduced enrollment numbers to beat earnings. Now CEO has awarded herself a 1106% raise and loaded up on debt at 15% per annum interest payments.

Churning in this range to move past 20$ soon

I bought this on a simulation account and am up over 140%.... Why didn't I do that with real money

I think FDA guys are better expert to evaluate people thought same about ANIK when it was trading at $3 now at 40$

Time will tell I will hold another quarter to see the chase

Dex-In trial in limbo, reduction of patient enrollment by 32%. Low sample size and slashing R&D is not the way to bring a drug to market.

Here is the link

http://finance.yahoo.com/news/recro-pharma-announces-going-phase-110000251.html

Cheers hold tight buddy my first sale $25 and next $ 33

Thanks for the heads up. Could you post a link?